210 related articles for article (PubMed ID: 27392970)
1. Regulation of Collagen V Expression and Epithelial-Mesenchymal Transition by miR-185 and miR-186 during Idiopathic Pulmonary Fibrosis.
Lei GS; Kline HL; Lee CH; Wilkes DS; Zhang C
Am J Pathol; 2016 Sep; 186(9):2310-6. PubMed ID: 27392970
[TBL] [Abstract][Full Text] [Related]
2. miR‑221 targets HMGA2 to inhibit bleomycin‑induced pulmonary fibrosis by regulating TGF‑β1/Smad3-induced EMT.
Wang YC; Liu JS; Tang HK; Nie J; Zhu JX; Wen LL; Guo QL
Int J Mol Med; 2016 Oct; 38(4):1208-16. PubMed ID: 27513632
[TBL] [Abstract][Full Text] [Related]
3. Integrated analyses identify the involvement of microRNA-26a in epithelial-mesenchymal transition during idiopathic pulmonary fibrosis.
Liang H; Gu Y; Li T; Zhang Y; Huangfu L; Hu M; Zhao D; Chen Y; Liu S; Dong Y; Li X; Lu Y; Yang B; Shan H
Cell Death Dis; 2014 May; 5(5):e1238. PubMed ID: 24853416
[TBL] [Abstract][Full Text] [Related]
4. miR-26a suppresses EMT by disrupting the Lin28B/let-7d axis: potential cross-talks among miRNAs in IPF.
Liang H; Liu S; Chen Y; Bai X; Liu L; Dong Y; Hu M; Su X; Chen Y; Huangfu L; Li X; Gu Y; Shan H
J Mol Med (Berl); 2016 Jun; 94(6):655-65. PubMed ID: 26787543
[TBL] [Abstract][Full Text] [Related]
5. miR-18a-5p Inhibits Sub-pleural Pulmonary Fibrosis by Targeting TGF-β Receptor II.
Zhang Q; Ye H; Xiang F; Song LJ; Zhou LL; Cai PC; Zhang JC; Yu F; Shi HZ; Su Y; Xin JB; Ma WL
Mol Ther; 2017 Mar; 25(3):728-738. PubMed ID: 28131417
[TBL] [Abstract][Full Text] [Related]
6. Regulation of myofibroblast differentiation by miR-424 during epithelial-to-mesenchymal transition.
Xiao X; Huang C; Zhao C; Gou X; Senavirathna LK; Hinsdale M; Lloyd P; Liu L
Arch Biochem Biophys; 2015 Jan; 566():49-57. PubMed ID: 25524739
[TBL] [Abstract][Full Text] [Related]
7. miR-130b-3p Modulates Epithelial-Mesenchymal Crosstalk in Lung Fibrosis by Targeting IGF-1.
Li S; Geng J; Xu X; Huang X; Leng D; Jiang D; Liang J; Wang C; Jiang D; Dai H
PLoS One; 2016; 11(3):e0150418. PubMed ID: 26953888
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-708-3p as a potential therapeutic target via the ADAM17-GATA/STAT3 axis in idiopathic pulmonary fibrosis.
Liu B; Li R; Zhang J; Meng C; Zhang J; Song X; Lv C
Exp Mol Med; 2018 Mar; 50(3):e465. PubMed ID: 29869625
[TBL] [Abstract][Full Text] [Related]
9. The effect of H19-miR-29b interaction on bleomycin-induced mouse model of idiopathic pulmonary fibrosis.
Tang Y; He R; An J; Deng P; Huang L; Yang W
Biochem Biophys Res Commun; 2016 Oct; 479(3):417-423. PubMed ID: 27613097
[TBL] [Abstract][Full Text] [Related]
10. Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis.
Chilosi M; Caliò A; Rossi A; Gilioli E; Pedica F; Montagna L; Pedron S; Confalonieri M; Doglioni C; Ziesche R; Grubinger M; Mikulits W; Poletti V
Mod Pathol; 2017 Jan; 30(1):26-38. PubMed ID: 27586205
[TBL] [Abstract][Full Text] [Related]
11. A novel lnc-PCF promotes the proliferation of TGF-β1-activated epithelial cells by targeting miR-344a-5p to regulate map3k11 in pulmonary fibrosis.
Liu H; Wang B; Zhang J; Zhang S; Wang Y; Zhang J; Lv C; Song X
Cell Death Dis; 2017 Oct; 8(10):e3137. PubMed ID: 29072702
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of permeability alteration and epithelial-mesenchymal transition induced by transforming growth factor-β
Togami K; Yamaguchi K; Chono S; Tada H
J Pharmacol Toxicol Methods; 2017 Jul; 86():19-27. PubMed ID: 28259823
[TBL] [Abstract][Full Text] [Related]
13. miR-34 miRNAs Regulate Cellular Senescence in Type II Alveolar Epithelial Cells of Patients with Idiopathic Pulmonary Fibrosis.
Disayabutr S; Kim EK; Cha SI; Green G; Naikawadi RP; Jones KD; Golden JA; Schroeder A; Matthay MA; Kukreja J; Erle DJ; Collard HR; Wolters PJ
PLoS One; 2016; 11(6):e0158367. PubMed ID: 27362652
[TBL] [Abstract][Full Text] [Related]
14. Interaction of long noncoding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis.
Huang C; Yang Y; Liu L
Physiol Genomics; 2015 Oct; 47(10):463-9. PubMed ID: 26269497
[TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in idiopathic pulmonary fibrosis, new research progress and their pathophysiological implication.
Miao C; Xiong Y; Zhang G; Chang J
Exp Lung Res; 2018 Apr; 44(3):178-190. PubMed ID: 29683754
[TBL] [Abstract][Full Text] [Related]
16. miRNA-181a inhibits the proliferation, migration, and epithelial-mesenchymal transition of lens epithelial cells.
Dong N; Tang X; Xu B
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):993-1001. PubMed ID: 25626972
[TBL] [Abstract][Full Text] [Related]
17. Tubastatin ameliorates pulmonary fibrosis by targeting the TGFβ-PI3K-Akt pathway.
Saito S; Zhuang Y; Shan B; Danchuk S; Luo F; Korfei M; Guenther A; Lasky JA
PLoS One; 2017; 12(10):e0186615. PubMed ID: 29045477
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-132/212 Upregulation Inhibits TGF-β-Mediated Epithelial-Mesenchymal Transition of Prostate Cancer Cells by Targeting SOX4.
Fu W; Tao T; Qi M; Wang L; Hu J; Li X; Xing N; Du R; Han B
Prostate; 2016 Dec; 76(16):1560-1570. PubMed ID: 27527117
[TBL] [Abstract][Full Text] [Related]
19. The role of miR-29 in pulmonary fibrosis.
Cushing L; Kuang P; Lü J
Biochem Cell Biol; 2015 Apr; 93(2):109-18. PubMed ID: 25454218
[TBL] [Abstract][Full Text] [Related]
20. Tannic acid attenuates TGF-β1-induced epithelial-to-mesenchymal transition by effectively intervening TGF-β signaling in lung epithelial cells.
Pattarayan D; Sivanantham A; Krishnaswami V; Loganathan L; Palanichamy R; Natesan S; Muthusamy K; Rajasekaran S
J Cell Physiol; 2018 Mar; 233(3):2513-2525. PubMed ID: 28771711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
